Drug safety updates, recalls and regulatory warnings from MHRA, organised for rapid clinical review and specialty follow-up.
#MedSafetyWeek 2026: Key Takeaways for Clinicians Encourage patient reporting: MedSafetyWeek (2-8 November 2026) emphasises the critical importance of reporting suspected adverse drug reactions and medical device incidents via the Yellow Card scheme to improve…
26 Oct 2026 · Read clinical summary#MedSafetyWeek 2026: Key Takeaways for Clinicians Encourage patient reporting: MedSafetyWeek (2-8 November 2026) emphasises the critical importance of reporting suspected adverse drug reactions and medical device incidents via…
IXCHIQ chikungunya vaccine marketing authorisation withdrawn in UK following CHM safety review, indicating benefit-risk profile no longer favourable Clinicians should cease prescribing and counsel patients already vaccinated about…
All antidepressants now require enhanced safety communication about risks of suicidal ideation/behaviour and persistent sexual dysfunction to ensure informed patient consent before treatment initiation New safety measures aim…
Parenteral nutrition must be administered through appropriate filters across all care settings to prevent particulate matter embolism, which can be fatal Non-filtered PN administration represents a significant patient…
Domperidone is now contraindicated in confirmed or suspected phaeochromocytoma due to risk of severe hypertensive episodes from catecholamine release All domperidone product information has been updated to reflect…
Botulinum toxin type A: Key clinical takeaways Iatrogenic botulism risk: Botulinum toxin type A can spread beyond injection sites, causing systemic botulism with serious consequences; clinicians must recognise…
Angioedema associated with ACE-inhibitors can present with delayed onset, requiring heightened clinical awareness and vigilance beyond initial prescription periods Bradykinin-mediated angioedema (ACE-inhibitor induced) requires different management from histamine-mediated…
Amiodarone carries serious risks of pulmonary, hepatic, and thyroid toxicity requiring baseline assessment and regular monitoring throughout treatment Patients on amiodarone require structured supervision with scheduled reviews to…
Amiodarone carries serious risks of pulmonary, hepatic, and thyroid toxicity requiring regular patient monitoring and supervision throughout treatment Healthcare professionals must ensure appropriate baseline investigations and regular follow-up…
The MHRA has identified suicidal thoughts and behaviours as a safety concern with finasteride and dutasteride, requiring additional risk minimisation measures in clinical practice. Psychiatric adverse effects and…
Nasal decongestant sprays/drops containing xylometazoline or oxymetazoline carry a risk of rebound congestion and rhinitis medicamentosa with overuse, requiring cautious patient counselling on duration of use. Tachyphylaxis (reduced…
A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with…